Technical Analysis for VRCA - Verrica Pharmaceuticals Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| A | 7.61 | -0.52% | -0.04 |
VRCA closed down 0.52 percent on Wednesday, May 8, 2024, on 52 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
Earnings due: May 13
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Bollinger Band Squeeze | Range Contraction | 0.00% | |
| Stochastic Reached Overbought | Strength | 0.00% | |
| Upper Bollinger Band Walk | Strength | 0.00% | |
| BB Squeeze + Upper Band Touch | Range Contraction | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Above Upper BB | Strength | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| Upper Bollinger Band Touch | Strength | 0.00% | |
| MACD Bullish Signal Line Cross | Bullish | -0.52% | |
| New 52 Week Closing High | Bullish | -0.52% |
| Alert | Time |
|---|---|
| Possible Inside Day | about 15 hours ago |
| 60 Minute Opening Range Breakout | about 17 hours ago |
| Up 1% | about 17 hours ago |
| Down 1% | about 19 hours ago |
| Fell Below Upper Bollinger Band | about 19 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/13/2024
Verrica is a pharmaceutical company focused on identifying, developing and commercializing innovative pharmaceutical products for the treatment of skin diseases with significant unmet needs. The company’s lead product candidate, VP-102, is currently being evaluated in two Phase 3 clinical trials for the treatment of molluscum and in a Phase 2 clinical trial for the treatment of common warts.
Sector: Healthcare
Industry: Biotechnology
Keywords: Pharmaceutical Medication Pharmaceutical Products Clinical Trial Skin Diseases Treatment Of Skin Diseases Common Warts
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Pharmaceutical Medication Pharmaceutical Products Clinical Trial Skin Diseases Treatment Of Skin Diseases Common Warts
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 7.79 |
| 52 Week Low | 2.86 |
| Average Volume | 166,223 |
| 200-Day Moving Average | 5.05 |
| 50-Day Moving Average | 6.13 |
| 20-Day Moving Average | 7.02 |
| 10-Day Moving Average | 7.11 |
| Average True Range | 0.37 |
| RSI (14) | 68.55 |
| ADX | 38.08 |
| +DI | 32.23 |
| -DI | 11.47 |
| Chandelier Exit (Long, 3 ATRs) | 6.69 |
| Chandelier Exit (Short, 3 ATRs) | 7.64 |
| Upper Bollinger Bands | 7.53 |
| Lower Bollinger Band | 6.50 |
| Percent B (%b) | 1.07 |
| BandWidth | 14.81 |
| MACD Line | 0.33 |
| MACD Signal Line | 0.31 |
| MACD Histogram | 0.0227 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 7.96 | ||||
| Resistance 3 (R3) | 7.96 | 7.86 | 7.90 | ||
| Resistance 2 (R2) | 7.86 | 7.77 | 7.85 | 7.88 | |
| Resistance 1 (R1) | 7.73 | 7.71 | 7.68 | 7.73 | 7.86 |
| Pivot Point | 7.63 | 7.63 | 7.60 | 7.62 | 7.63 |
| Support 1 (S1) | 7.50 | 7.54 | 7.45 | 7.50 | 7.36 |
| Support 2 (S2) | 7.40 | 7.48 | 7.39 | 7.34 | |
| Support 3 (S3) | 7.27 | 7.40 | 7.32 | ||
| Support 4 (S4) | 7.27 |
